Literature DB >> 12021342

Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.

Eishiro Mizukoshi1, Michelina Nascimbeni, Joshua B Blaustein, Kathleen Mihalik, Charles M Rice, T Jake Liang, Stephen M Feinstone, Barbara Rehermann.   

Abstract

The chimpanzee is a critical animal model for studying cellular immune responses to infectious pathogens such as hepatitis B and C viruses, human immunodeficiency virus, and malaria. Several candidate vaccines and immunotherapies for these infections aim at the induction or enhancement of cellular immune responses against viral epitopes presented by common human major histocompatibility complex (MHC) alleles. To identify and characterize chimpanzee MHC class I molecules that are functionally related to human alleles, we sequenced 18 different Pan troglodytes (Patr) alleles of 14 chimpanzees, 2 of them previously unknown and 3 with only partially reported sequences. Comparative analysis of Patr binding pockets and binding assays with biotinylated peptides demonstrated a molecular homology between the binding grooves of individual Patr alleles and the common human alleles HLA-A1, -A2, -A3, and -B7. Using cytotoxic T cells isolated from the blood of hepatitis C virus (HCV)-infected chimpanzees, we then mapped the Patr restriction of these HCV peptides and demonstrated functional homology between the Patr-HLA orthologues in cytotoxicity and gamma interferon (IFN-gamma) release assays. Based on these results, 21 HCV epitopes were selected to characterize the chimpanzees' cellular immune response to HCV. In each case, IFN-gamma-producing T cells were detectable in the blood after but not prior to HCV infection and were specifically targeted against those HCV peptides predicted by Patr-HLA homology. This study demonstrates a close functional homology between individual Patr and HLA alleles and shows that HCV infection generates HCV peptides that are recognized by both chimpanzees and humans with Patr and HLA orthologues. These results are relevant for the design and evaluation of vaccines in chimpanzees that can now be selected according to the most frequent human MHC haplotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021342      PMCID: PMC136197          DOI: 10.1128/jvi.76.12.6093-6103.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Evolution of the HOXB6 intergenic region: motif conservation at the lateral plate mesoderm (LPM) enhancer element.

Authors:  A Deinard; R Dorit; C Castiglione; Z Jiang; D Becker; F Ruddle; K Schugart; K Kidd
Journal:  J Exp Zool       Date:  1999-08-15

Review 2.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

3.  Mitochondrial sequences show diverse evolutionary histories of African hominoids.

Authors:  P Gagneux; C Wills; U Gerloff; D Tautz; P A Morin; C Boesch; B Fruth; G Hohmann; O A Ryder; D S Woodruff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 4.  Conservation and diversification of MHC class I and its related molecules in vertebrates.

Authors:  K Hashimoto; K Okamura; H Yamaguchi; M Ototake; T Nakanishi; Y Kurosawa
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

5.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

Authors:  A Takaki; M Wiese; G Maertens; E Depla; U Seifert; A Liebetrau; J L Miller; M P Manns; B Rehermann
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Molecular analyses of five new chimpanzee MHC class I alleles: implications for differences between evolutional mechanisms of HLA-A, -B, and -C loci.

Authors:  M Matsui; S Machida; S M Feinstone; T Akatsuka
Journal:  Biochem Biophys Res Commun       Date:  1999-07-22       Impact factor: 3.575

7.  CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.

Authors:  F Lechner; N H Gruener; S Urbani; J Uggeri; T Santantonio; A R Kammer; A Cerny; R Phillips; C Ferrari; G R Pape; P Klenerman
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

8.  Major histocompatibility complex class I diversity in a West African chimpanzee population: implications for HIV research.

Authors:  N G de Groot; N Otting; R Argüello; D I Watkins; G G Doxiadis; J A Madrigal; R E Bontrop
Journal:  Immunogenetics       Date:  2000-05       Impact factor: 2.846

9.  Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.

Authors:  B Rehermann; K M Chang; J McHutchinson; R Kokka; M Houghton; C M Rice; F V Chisari
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.

Authors:  M Cucchiarini; A R Kammer; B Grabscheid; H M Diepolder; T J Gerlach; N Grüner; T Santantonio; J Reichen; G R Pape; A Cerny
Journal:  Cell Immunol       Date:  2000-08-01       Impact factor: 4.868

View more
  9 in total

1.  Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors:  Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

2.  Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.

Authors:  Michael Gleimer; Angela R Wahl; Heather D Hickman; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; John A Hammond; Monia Draghi; Erin J Adams; Sean Juo; Roxana Jalili; Baback Gharizadeh; Mostafa Ronaghi; K Christopher Garcia; William H Hildebrand; Peter Parham
Journal:  J Immunol       Date:  2011-01-05       Impact factor: 5.422

3.  Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.

Authors:  Su-Hyung Park; Eui-Cheol Shin; Stefania Capone; Laura Caggiari; Valli De Re; Alfredo Nicosia; Antonella Folgori; Barbara Rehermann
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

4.  Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Authors:  Michelina Nascimbeni; Eishiro Mizukoshi; Markus Bosmann; Marian E Major; Kathleen Mihalik; Charles M Rice; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C.

Authors:  Tobias Manigold; Eui-Cheol Shin; Eishiro Mizukoshi; Kathleen Mihalik; Krishna K Murthy; Charles M Rice; Ciriaco A Piccirillo; Barbara Rehermann
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

7.  The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.

Authors:  Michael Thomson; Michelina Nascimbeni; Michael B Havert; Marian Major; Sophia Gonzales; Harvey Alter; Stephen M Feinstone; Krishna K Murthy; Barbara Rehermann; T Jake Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Prediction of T-cell epitopes of hepatitis C virus genotype 5a.

Authors:  Maemu P Gededzha; M Jeffrey Mphahlele; Selokela G Selabe
Journal:  Virol J       Date:  2014-11-08       Impact factor: 4.099

9.  Similar patterns of genetic diversity and linkage disequilibrium in Western chimpanzees (Pan troglodytes verus) and humans indicate highly conserved mechanisms of MHC molecular evolution.

Authors:  Christelle Vangenot; José Manuel Nunes; Gaby M Doxiadis; Estella S Poloni; Ronald E Bontrop; Natasja G de Groot; Alicia Sanchez-Mazas
Journal:  BMC Evol Biol       Date:  2020-09-15       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.